The Tyrphostin Agent AG490 Prevents and Reverses Type 1 Diabetes in NOD Mice
Abdoreza Davoodi‐Semiromi(American Association of Colleges of Pharmacy), Mark A. Atkinson(University of Florida)
Cited by 21
Related Papers
Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes
|Nature|1998|641
Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes.
|Journal of Clinical Investigation|1994|457
A Map of Human Type 1 Diabetes Progression by Imaging Mass Cytometry
|Cell Metabolism|2019|317
The intestinal microbiome in type 1 diabetes
|Clinical & Experimental Immunology|2014|125
Immunophenotyping assessment in a COVID-19 cohort (IMPACC): A prospective longitudinal study
|Science Immunology|2021|74